About Kester Phillips, MD
While working as a senior research technician in the lab of David Sulzer, PhD, at New York Presbyterian Medical Center, Dr. Phillips coauthored papers that provided insights to key molecular and neuroinflammatory pathways underpinning the pathogenesis of Parkinson’s disease. However, during his Neuro-Oncology rotation at Memorial Sloan Kettering Cancer Center for his neurology residency, he developed a renewed interest in the treatment of patients with brain tumors.
After his residency at SUNY Downstate Medical Center, Dr. Phillips completed his Neuro-Oncology fellowship at Harvard Medical School Beth Israel Deaconess Medical Center in Boston under the guidance of Eric T. Wong, MD and at the Neuro-Oncology Center at the University of Virginia under the mentorship of David Schiff, MD and Camilo E. Fadul, MD.
Dr. Phillips is the only neurology-trained board certified neuro-oncologist is Northern Virginia. He is an expert in the treatment of patients with glioblastoma, astrocytoma, oligodendroglioma, primary CNS lymphoma, meningioma, medulloblastoma, hemangioblastoma, ependymoma, pituitary tumors, brain metastases, spinal cord tumors and those affected by neurologic complications from cancer or cancer therapy.
His goal is to deliver the best coordinated care to patients with brain and spinal tumors. Dr. Phillips connects with his patients through a personable and compassionate approach to cancer care. His research interest includes participating in translational studies and clinical trials to improve therapeutic approaches in the treatment of patients with brain tumors.
A native of Brooklyn, New York, Dr. Phillips currently lives in Alexandria, Virginia. In his spare time, he enjoys cooking, gardening, playing tennis, biking, hiking, traveling and spending time with his children.
- Ross University School of Medicine, High Honors Distinction Diploma
- Nubian Conservatory of Music Board of Directors
- Beth Israel Deaconess Academy of Medical Educators
- Society for Neuro-Oncology, Member
- Martucci MG, McIlduff CE, Shin C, Gutierrez HV, Nam JY, Greenstein P, Phillips K, Uhlmann EJ, Wong ET, Rutkove SB. Quantitative ultrasound of muscle can detect corticosteroid effects. Clin Neurophysiol. 2019 Aug;130(8):1460-1464.
- Phillips KA, Fadul CE, Schiff D. Neurologic and Medical Management of Brain Tumors. In: Neurol Clin. Vol 36. United States: 2018 Elsevier Inc; 2018:449-466.
- Phillips KA, Gaughan E, Gru A, Schiff D. Regression of an intramedullary spinal cord metastasis with a checkpoint inhibitor: a case report. CNS Oncol. 2017;6(4):275-280.
- Zhang W, Phillips K, Wielgus AR, et al. Neuromelanin activates microglia and induces degeneration of dopaminergic neurons: implications for progression of Parkinson's disease. Neurotox Res. 2011;19(1):63-72.
- Mosharov EV, Larsen KE, Kanter E, et al. Interplay between cytosolic dopamine, calcium, and alpha-synuclein causes selective death of substantia nigra neurons. Neuron. 2009;62(2):218-229.
- Larsen KE, Benn SC, Ay I, et al. A glial cell line-derived neurotrophic factor (GDNF): tetanus toxin fragment C protein conjugate improves delivery of GDNF to spinal cord motor neurons in mice. In: Brain Res. Vol 1120. Netherlands2006:1-12.
Phillips KA, Schiff D. Basic Principles of Brain Tumor Chemotherapy. In: Paleologos NA and Newton HB, (eds). Oligodendroglioma: Clinical Presentation, Pathology, Molecular Biology, Imaging, and Treatment, San Diego: Elsevier Inc./Academic Press, 2019: 309-329.